<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95636">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01734356</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/10/11-P</org_study_id>
    <nct_id>NCT01734356</nct_id>
  </id_info>
  <brief_title>Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells</brief_title>
  <acronym>Diag-iPS</acronym>
  <official_title>Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <authority>France : Agence Française de Sécurité Sanitaire des Produits de Santé</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The recent developments of research on iPS (induced pluripotent stem) cells lead to the
      establishment of mature cell lines such as cardiomyocytes or valvular interstitial cells
      with genetic and cellular characteristics of the donors. These cells represent a biological
      material more readily available to identify the pathophysiological mechanisms involved in
      the diseases of BrS or ERS patients, which will lead to the identification of genetic
      markers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Production of cardiomyocytes modele from skin fibroblast of arrhythmic patient</measure>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Production of valve interstitial cells modele from skin fibroblast of patient with a valvulopathy</measure>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Inherited Arrhythmias and Valvulopathies</condition>
  <arm_group>
    <arm_group_label>inherited arrhythmias</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>6 patient with inherited arrhythmias</description>
  </arm_group>
  <arm_group>
    <arm_group_label>valvulopathies</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>6 patient with valvulopathies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controle</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>8 healthy people for these pathologies</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Skin biopsies</intervention_name>
    <arm_group_label>inherited arrhythmias</arm_group_label>
    <arm_group_label>valvulopathies</arm_group_label>
    <arm_group_label>controle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patient with a family history of inherited arrhythmia or valvulopathy

          -  Age : 22-60 yo.

          -  patient no confine to bed

          -  Male or female

          -  Written consent

          -  Patient affiliated to the French social security

        Exclusion criteria:

          -  Pregnant woman

          -  Patient under 22 yo or adults under guardianship

          -  Indication against local anesthesia

          -  Anticoagulant treatment

          -  Absence or positivity of HIV, HBV, HCV serology
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent PROBST</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes UH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gildas LOUSSOUARN</last_name>
    <phone>02 28 08 01 50</phone>
    <email>gildas.loussouarn@inserm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gildas LOUSSOUARN</last_name>
      <phone>02 28 08 01 30</phone>
      <email>gildas.loussouarn@inserm.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent PROBST</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 7, 2014</lastchanged_date>
  <firstreceived_date>November 22, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>iPS</keyword>
  <keyword>fibroblast</keyword>
  <keyword>arrhythmias</keyword>
  <keyword>valvulopathies</keyword>
  <keyword>electrophysiology</keyword>
  <keyword>genetics</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
